Department of Epidemiology, University of Washington, Seattle, WA 98104-2499, USA.
Sex Transm Dis. 2013 Mar;40(3):221-5. doi: 10.1097/OLQ.0b013e318272fe45.
In Africa, data on Chlamydia trachomatis infection are scarce because reliable diagnosis is costly and not widely available. Our objective was to evaluate the incidence and correlates of C. trachomatis infection among high-risk Kenyan women.
We conducted prospective cohort analyses using data from a cohort of women who reported transactional sex. C. trachomatis testing was performed using the Gen-Probe Aptima GC/CT Detection System. We used Andersen-Gill proportional hazards modeling to evaluate correlates of C. trachomatis.
Between August 2006 and December 2010, 865 women contributed 2011 person-years of observation. Sixty-four women experienced 101 episodes of C. trachomatis infection (incidence rate, 5.0/100 person-years). There was a large difference in incidence by age group: those younger than 25 years had an incidence of 27.6 per 100 person-years (95% confidence interval [CI], 16.3-46.5), those 25 to 34 years old had an incidence of 8.4 per 100 person-years (95% CI, 6.4-11.0), and those 35 years and older had an incidence of 2.6 per 100 person-years (95% CI, 1.8-3.6). In multivariate analyses, younger age (<25 and 25-34 years vs. ≥35 years; hazard ratio [HR], 8.5 [95% CI, 4.1-17.7] and 2.9 [95% CI, 1.7-5.0], respectively), depot medroxyprogesterone acetate use (HR, 1.8; 95% CI, 1.1-3.0), and recent Neisseria gonorrhoeae infection (HR, 3.3; 95% CI, 1.5-7.4) were significantly associated with increased risk of acquiring C. trachomatis infection.
The high incidence of C. trachomatis among younger high-risk women suggests the need for screening as an important public health intervention for this population.
在非洲,有关沙眼衣原体感染的数据很少,因为可靠的诊断费用高昂且无法广泛获得。我们的目的是评估肯尼亚高危女性中沙眼衣原体感染的发生率和相关因素。
我们对报告有商业性行为的女性队列进行了前瞻性队列分析。使用 Gen-Probe Aptima GC/CT 检测系统进行沙眼衣原体检测。我们使用 Andersen-Gill 比例风险模型来评估沙眼衣原体的相关因素。
2006 年 8 月至 2010 年 12 月,865 名女性共提供了 2011 人年的观察期。64 名女性经历了 101 次沙眼衣原体感染(发生率为 5.0/100 人年)。按年龄组划分,发生率存在很大差异:年龄小于 25 岁的发生率为 27.6/100 人年(95%置信区间[CI],16.3-46.5),年龄在 25-34 岁的发生率为 8.4/100 人年(95%CI,6.4-11.0),年龄在 35 岁及以上的发生率为 2.6/100 人年(95%CI,1.8-3.6)。多变量分析显示,年龄较小(<25 岁和 25-34 岁 vs. ≥35 岁;危险比[HR],8.5[95%CI,4.1-17.7]和 2.9[95%CI,1.7-5.0])、使用 depot 醋酸甲羟孕酮(HR,1.8;95%CI,1.1-3.0)和近期淋病奈瑟菌感染(HR,3.3;95%CI,1.5-7.4)与感染沙眼衣原体的风险增加显著相关。
年轻高危女性中沙眼衣原体的高发生率表明,需要将筛查作为该人群的一项重要公共卫生干预措施。